TOKYO - Mitsui Chemicals Inc. and the government-backed Development Bank of Japan (DBJ) announced a definitive acquisition agreement on Monday, November 9. The deal acquires premier semiconductor materials manufacturer JSR Corporation for approximately 1.84 trillion yen ($11.6 billion). The consortium is acquiring full ownership from state-backed fund Japan Investment Corp (JIC). It completes the largest industrial reorganization across Japan's semiconductor materials manufacturing sector.
Mitsui Chemicals financing structure and JSR EUV photoresist market role
Global semiconductor supply chain participants closely analyzed the transaction. Detailed regulatory disclosures submitted to the Tokyo Stock Exchange outlined a multi-layered acquisition financing framework. Mitsui Chemicals will hold the controlling equity interest. The structure is supported by a 200-billion-yen capital injection from the DBJ and a 1.64-trillion-yen commercial bank bridge loan facility.
Mitsui Chemicals also registered a 150-billion-yen public share offering. The offering aims to optimize equity reserves following the acquisition. Headquartered in Tokyo, JSR commands a dominant global market share in extreme ultraviolet (EUV) photoresists and advanced microelectronic packaging chemicals. Its customer base includes leading commercial fabrication foundries such as TSMC, Intel Corporation, and Samsung Electronics.
JIC originally privatized JSR in 2024 for approximately 900 billion yen. The move consolidated domestic semiconductor supply chain infrastructure. It preceded returning the business to corporate industrial ownership. The President and Chief Executive Officer of Mitsui Chemicals addressed reporters during a joint media conference in Tokyo: "Acquiring JSR represents a transformative leap forward in advanced semiconductor materials, allowing us to combine specialized chemistries and provide unmatched material capabilities to global chipmakers."
Analysts welcome deal combining EUV pellicles with JSR photoresists
Financial analysts in Tokyo welcomed the announcement. The transaction combines Mitsui Chemicals' monopoly in EUV pellicles with JSR's specialized chemical formulations. EUV pellicles are protective membranes guarding multi-million-dollar lithography photomasks from microscopic airborne particulate contamination. Integrating pellicle hardware and photoresist chemistries allows the unified entity to deliver comprehensive lithography materials suites to fabrication plants.
Those plants are advancing 2-nanometer and sub-nanometer node architectures. Japan's Ministry of Economy, Trade and Industry (METI) issued a supportive statement on Monday. It underscored that sovereign materials consolidation safeguards Japan's strategic industrial leadership. The transaction remains subject to customary antitrust reviews across the United States, China, South Korea, and the European Union.
Formal transaction closing is projected for the second quarter of 2027.
Vertical integration creates materials champion with 70% market share
The multi-billion-dollar acquisition of JSR Corporation by Mitsui Chemicals represents a decisive structural consolidation across Japan's high-tech microelectronics materials industry. Financial analysts and semiconductor market researchers emphasized the combination of two asset bases. JSR's pioneering extreme ultraviolet photoresist formulations join Mitsui Chemicals' dominant manufacturing infrastructure for EUV pellicle membranes. This constructs a vertically integrated materials champion.
This unified supply chain presence provides international chip foundries with a coordinated technical partner. That partner is capable of co-developing next-generation chemical solutions required for sub-2-nanometer fabrication processes. Global semiconductor trade associations highlighted that specialized chemical consumables represent one of the most critical competitive bottlenecks in modern microchip manufacturing. By consolidating proprietary patent portfolios and centralizing capital expenditures under corporate management, Japan preserves its commanding 70% market share across key lithography chemical categories.
The transaction reflects a strategic national commitment. It anchors foundational semiconductor material capabilities domestically while supporting the technological roadmaps of leading international foundries globally. Microelectronics industry analysts observed that combining specialized chemical research capabilities with advanced manufacturing scale empowers domestic suppliers. It helps them meet soaring global demand for artificial intelligence hardware.
Consolidated entity to accelerate prototyping with global foundries
The consolidated entity will accelerate collaborative product prototyping with leading international foundries. This reinforces long-term innovation across advanced semiconductor packaging. Financial advisers underscored that disciplined capital allocation and vertical supply integration enable advanced materials producers to deliver sustainable long-term value across global microelectronics markets. International industry analysts and regional observers confirmed that transparent governance standards ensure lasting economic resilience and technological progress across global markets.
